Commission Regulation (EC) No 6/2006 of  5 January 2006  amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards dihydrostreptomycin, tosylchloramide sodium and  Piceae turiones recentes extractum   (Text with EEA relevance)
Date: 2006-01-05
Institutions: European Commission
Subjects: animal nutrition, manufactured feedingstuffs, veterinary drug, veterinary legislation

6.1.2006

EN

Official Journal of the European Union

L 3/3

COMMISSION REGULATION (EC) No 6/2006

of 5 January 2006

amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community
procedure for the establishment of maximum residue limits of veterinary medicinal products in
foodstuffs of animal origin, as regards dihydrostreptomycin, tosylchloramide sodium and Piceae
turiones recentes extractum

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(3)

Tosylchloramide has been included in Annex II to Regu-
lation (EEC) No 2377/90 for fin fish for water borne
only and for bovine for topical use only. That entry
should be extended to Equidae for topical use only.

Having regard to the Treaty
Community,

establishing the European

(4)

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), and in particular
Articles 2 and 3 thereof,

turiones

for Piceae

An application for establishing of maximum residue
extractum has been
limits
submitted. This substance should be included in Annex
II to that Regulation for all food producing species for
oral use only.

recentes

(5)

Regulation (EEC) No 2377/90 should be amended
accordingly.

Having regard to the opinions of
the European Medicines
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

(6)

Whereas:

An adequate period should be allowed before the appli-
cability of this Regulation in order to enable Member
States to make any adjustment which may be necessary
in the light of this Regulation to the marketing author-
accordance with Directive
isations
2001/82/EC of
the
Council of 6 November 2001 on the Community code
relating to veterinary medicinal products (2).

the European Parliament and of

granted

in

(1)

(2)

All pharmacologically active substances which are used
within the Community in veterinary medicinal products
intended for administration to food-producing animals
should be evaluated in accordance with Regulation
(EEC) No 2377/90.

(7)

The measures provided for in this Regulation are in
accordance with
Standing
the
the
Committee on Veterinary Medicinal Products,

opinion

of

Dihydrostreptomycin has been included in Annex I to
Regulation (EEC) No 2377/90 for bovine and ovine
species, for muscle, fat, liver, kidney and milk, and for
porcine species for muscle, liver, kidney and skin and fat
in natural proportions. That entry should be extended
from bovine and ovine species to all ruminants.

(1) OJ L 224, 18.8.1990, p. 1. Regulation as

(EC) No 1911/2005 (OJ

last amended by
L 305,

Commission Regulation
24.11.2005, p. 30).

HAS ADOPTED THIS REGULATION:

Article 1

Annexes I and II to Regulation (EEC) No 2377/90 are amended
in accordance with the Annex to this Regulation.

(2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive

2004/28/EC (OJ L 136, 30.4.2004, p. 58).

L 3/4

EN

Official Journal of the European Union

6.1.2006

This Regulation shall enter into force on the third day following that of its publication in the Official Journal
of the European Union.

Article 2

It shall apply from 7 March 2006.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 January 2006.

For the Commission

Günter VERHEUGEN
Vice-President

6.1.2006

EN

Official Journal of the European Union

L 3/5

s
e
u
s
s
i
t

t
e
g
r
a
T

e
l
c
s
u
M

r
e
v
i
L

t
a
F

y
e
n
d
K

i

’

k

l
i

M

g
k
/
g

μ

0
0
5

g
k
/
g

μ

0
0
5

g
k
/
g

μ

0
0
5

s
L
R
M

g
k
/
g

μ

0
0
2

g
k
/
g

μ

0
0
0
1

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

s
t
n
a
n
m
u
r

i

l
l
a

n
i
c
y
m
o
t
p
e
r
t
s
o
r
d
y
h
D

i

n
i
c
y
m
o
t
p
e
r
t
s
o
r
d
y
h
D

i

‘

s
e
d
i
s
o
c
y
l
g
o
n
m
A

i

.

.

0
1
2
1

.

X
E
N
N
A

:

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

s
i

e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

A

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

.

1

i

s
c
i
t
o
b
i
t
n
A

.

2
1

.

)
1
(

i

e
a
d
u
q
E

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

m
u
i
d
o
s

e
d
i
m
a
r
o
h
c
l
y
s
o
T

l

‘

’

.

y
l
n
o

e
s
u

l
a
c
i
p
o
t

r
o
F

)
1
(

s
d
n
u
o
p
m
o
c

c
i
n
a
g
r
O

.

2

n
i
g
i
r
o

e
l
b
a
t
e
g
e
v

f
o

s
e
c
n
a
t
s
b
u
S

.

6

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
1
(

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

m
u
t
c
a
r
t
x
e

s
e
t
n
e
c
e
r

s
e
n
o
i
r
u
t

e
a
e
c
i
P

‘

’

.

y
l
n
o

e
s
u

l
a
r
o

r
o
F

)
1
(

:

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

e
r
a

s
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

B